Bitcoin’s Soaring Potential as a Global Store of Value: A Charming Conversation with Strike CEO Jack Mallers Once upon a time in the enchanted land of cryptocurrencies, there lived a charismatic CEO named Jack Mallers. He was the proud leader of Strike, a fintech company that aimed to make Bitcoin (BTC) the preferred currency for…
The Famous Investor’s Victory Lap: A Look Back at Past Predictions In the ever-volatile world of finance and investments, there are few figures as iconic and influential as John Doe. With a career spanning decades and a track record of prescient calls, Doe has earned a reputation as a visionary in the industry. And now,…
Types of land tenure systems in Uganda Understanding land tenure in Uganda Land in Uganda belongs to the people of Uganda and shall vest in them in accordance with the land tenure systems provided for in the National Constitution. Therefore, land tenure refers to the relationship, whether legally or customarily defined, among people, as individuals…
Bronstein, Gewirtz & Grossman, LLC Files Class Action Lawsuit Against FTAI Aviation Ltd. New York, NY – In a significant development for investors, Bronstein, Gewirtz & Grossman, LLC, a well-known law firm, has announced the filing of a class action lawsuit against FTAI Aviation Ltd. (“FTAI Aviation” or “the Company”) (NASDAQ: FTAI) and certain of…
FRMO Corporation (OTCPK:FRMO) Q2 2025 Earnings Conference Call Overview Company Participants Thérèse Byars – Corporate Secretary Murray Stahl – Chairman & Chief Executive Officer Conference Call Participants Thérèse Byars Good afternoon, everyone. This is Thérèse Byars speaking, and I’m the Corporate Secretary of FRMO Corp. Thank you for joining us on this call. Today, we…
October 29, 2024 Announcement no. 20 First Patient In – BioPorto Initiates Patient Enrollment for US Study of ProNephro AKI (NGAL)™ for Adult Use at Massachusetts General Hospital COPENHAGEN, Denmark and BOSTON, MA, USA, October 29, 2024, (GLOBE NEWSWIRE) – BioPorto A/S (BioPorto or Company) (CPH:BIOPOR), an in vitro diagnostics company focused on empowering the…
Actinium Pharmaceuticals Initiates First Clinical Trial for Actimab-A Triplet Combination in AML Actinium Pharmaceuticals, a trailblazer in the field of targeted radiotherapies, has announced the initiation of a new clinical trial under a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI). This trial, identified by the number NCT06802523, will explore the…
Exciting News for MRC Global Inc. Agrees to Repurchase Preferred Stock Launching Term Loan B Financing and Pursuing Amendment to ABL Facility It’s always a great feeling when a company you’ve invested in announces positive news that will benefit both the company and its shareholders. MRC Global Inc. recently made headlines by agreeing to repurchase…
